TORONTO, Nov. 17 /CNW/ - Patheon (TSX: PTI - News), a global provider of drug development and manufacturing services to the international pharmaceutical industry and Senopsys LLC, a specialty pharmaceutical services company, have formed an alliance to develop dose formulations which enhance palatability (taste) for drugs that are in development.
